Target Price | $175.50 |
Price | $162.80 |
Potential | 7.80% |
Number of Estimates | 20 |
20 Analysts have issued a price target Procter & Gamble 2026 . The average Procter & Gamble target price is $175.50. This is 7.80% higher than the current stock price. The highest price target is $190.00 16.71% , the lowest is $152.00 6.63% . | |
A rating was issued by 25 analysts: 17 Analysts recommend Procter & Gamble to buy, 7 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Procter & Gamble stock has an average upside potential 2026 of 7.80% . Most analysts recommend the Procter & Gamble stock at Purchase. |
19 Analysts have issued a sales forecast Procter & Gamble 2025 . The average Procter & Gamble sales estimate is $84.2b . This is 0.34% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $84.6b 0.85% , the lowest is $83.7b 0.26% .
This results in the following potential growth metrics:
2024 | $84.0b | 2.48% |
---|---|---|
2025 | $84.2b | 0.21% |
2026 | $86.6b | 2.84% |
2027 | $89.8b | 3.72% |
2028 | $94.1b | 4.74% |
16 Analysts have issued an Procter & Gamble EBITDA forecast 2025. The average Procter & Gamble EBITDA estimate is $23.3b . This is 0.19% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $23.5b 1.00% , the lowest is $22.5b 3.30% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $23.2b | 9.53% |
---|---|---|
2025 | $23.3b | 0.33% |
2026 | $24.2b | 4.08% |
2027 | $25.5b | 5.47% |
2028 | $26.4b | 3.40% |
2024 | 27.59% | 6.88% |
---|---|---|
2025 | 27.62% | 0.11% |
2026 | 27.96% | 1.23% |
2027 | 28.43% | 1.68% |
2028 | 28.06% | 1.30% |
10 Procter & Gamble Analysts have issued a net profit forecast 2025. The average Procter & Gamble net profit estimate is $15.4b . This is 1.58% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $15.9b 4.85% , the lowest is $15.1b 1.01% .
This results in the following potential growth metrics and future Net Margins:
2024 | $14.6b | 1.56% |
---|---|---|
2025 | $15.4b | 5.83% |
2026 | $16.4b | 5.97% |
2027 | $17.5b | 6.99% |
2028 | $18.7b | 6.73% |
2024 | 17.37% | 0.90% |
---|---|---|
2025 | 18.34% | 5.60% |
2026 | 18.90% | 3.05% |
2027 | 19.49% | 3.12% |
2028 | 19.87% | 1.95% |
10 Analysts have issued a Procter & Gamble forecast for earnings per share. The average Procter & Gamble EPS is $6.59 . This is 6.29% higher than earnings per share in the financial year 2024. The highest EPS forecast is $6.80 9.68% , the lowest is $6.42 3.55% .
This results in the following potential growth metrics and future valuations:
2024 | $5.90 | 2.08% |
---|---|---|
2025 | $6.59 | 11.69% |
2026 | $6.98 | 5.92% |
2027 | $7.47 | 7.02% |
2028 | $7.97 | 6.69% |
Current | 26.26 | 4.25% |
---|---|---|
2025 | 24.71 | 5.90% |
2026 | 23.32 | 5.63% |
2027 | 21.80 | 6.52% |
2028 | 20.42 | 6.33% |
Based on analysts' sales estimates for 2025, the Procter & Gamble stock is valued at an EV/Sales of 4.83 and an P/S ratio of 4.53 .
This results in the following potential growth metrics and future valuations:
Current | 4.85 | 1.42% |
---|---|---|
2025 | 4.83 | 0.42% |
2026 | 4.70 | 2.76% |
2027 | 4.53 | 3.59% |
2028 | 4.32 | 4.52% |
Current | 4.55 | 1.56% |
---|---|---|
2025 | 4.53 | 0.34% |
2026 | 4.41 | 2.76% |
2027 | 4.25 | 3.59% |
2028 | 4.06 | 4.52% |
Procter & Gamble...
Analyst | Rating | Action | Date |
---|---|---|---|
Evercore ISI Group |
Outperform
➜
Outperform
|
Unchanged | Jun 03 2025 |
Piper Sandler |
Neutral
➜
Neutral
|
Unchanged | May 05 2025 |
B of A Securities |
Buy
➜
Buy
|
Unchanged | Apr 25 2025 |
Raymond James |
Outperform
➜
Outperform
|
Unchanged | Apr 25 2025 |
Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Apr 25 2025 |
Citigroup |
Buy
➜
Buy
|
Unchanged | Apr 25 2025 |
RBC Capital |
Sector Perform
➜
Outperform
|
Upgrade | Apr 25 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Evercore ISI Group:
Outperform
➜
Outperform
|
Jun 03 2025 |
Unchanged
Piper Sandler:
Neutral
➜
Neutral
|
May 05 2025 |
Unchanged
B of A Securities:
Buy
➜
Buy
|
Apr 25 2025 |
Unchanged
Raymond James:
Outperform
➜
Outperform
|
Apr 25 2025 |
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Apr 25 2025 |
Unchanged
Citigroup:
Buy
➜
Buy
|
Apr 25 2025 |
Upgrade
RBC Capital:
Sector Perform
➜
Outperform
|
Apr 25 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.